![Stephen Toovey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 69 $ al 31/07/2026
Stephen Toovey was the founder of Shanghai Ark Biopharmaceutical Co., Ltd., founded in 2014, where the title held was Chief Marketing Officer from 2014 to 2020.
Dr. Toovey currently holds the position of Independent Director at 60 Degrees Pharmaceuticals, Inc., starting in 2023.
The education history includes a doctorate degree from Ghent University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/07/2026 | 59 ( 0 % ) | 69 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 12/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Fundador | 01/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. BiotechnologyHealth Technology Develops drugs and biopharmaceuticals for respiratory diseases | Health Technology |
60 Degrees Pharmaceuticals, Inc.
 60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
